Carregant...
Ranolazine for the Suppression of Ventricular Arrhythmia: A Case Series
BACKGROUND: Premature ventricular complexes (PVCs) and ventricular tachycardia (VT) are associated with persistent symptoms and ventricular dysfunction. Approved medical therapies have undesirable side effects and proarrhythmic liability. Ranolazine is a novel antianginal that preferentially blocks...
Guardat en:
| Publicat a: | Ann Noninvasive Electrocardiol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931933/ https://ncbi.nlm.nih.gov/pubmed/24533675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/anec.12137 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|